Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8563565 Pyrazoloquinoline derivatives

Patent 8563565 was granted and assigned to Eisai on October, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

October 22, 2013

0

Patent Application Number

136447450

Date Filed

October 4, 2012

0

Patent Citations Received

US Patent 12077539 Imidazole and triazole KRAS inhibitors

0

US Patent 11939328 Quinoline compounds as inhibitors of KRAS

0

US Patent 11999752 Vinyl imidazole compounds as inhibitors of KRAS

0

US Patent 12006319 Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one

0

US Patent 11684652 HMGB1 antagonist treatment of acute lung injury

0

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

US Patent 11833146 Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil

0

US Patent 11883461 HMGB1 antagonist treatment of severe sepsis

0

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8563565 Pyrazoloquinoline derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool